Cost-of-illness analysis highlights the economic burden of inherited retinal dystrophies, suggesting critical investments for policy improvements.
This study highlights the substantial clinical and economic burden of IRDs on Belgian society. Therefore, it is important to continue investing in research and development, as well as to consider the substantial societal impact of these conditions in decision-making and shaping policy changes for Belgium. Future investments informed by these findings can contribute to decreasing the burden on society and enhance the well-being, inclusion and productivity of patients and caregivers.
No takes yet. Share an insight, caveat, or question.
Vandersmissen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: